Product Information
FENOFIBRATE 48 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.0916 per EA under NDC 69315028709. Its NADAC has been published 124 times since May 24, 2023.
FDA first approved this application on Mar 18, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
48 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315028709
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211122FDA Approved
3/18/2020
TE Code
AB
On Market Since
7/18/2022
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 48 MG TABLET has been published 124 times since May 24, 2023, and over the history we have for it it has declined 12.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0916 per EA |
|---|---|
| All-time high | $0.1231 (Feb 14, 2024) |
| All-time low | $0.0847 (Apr 17, 2024) |
| 52-week high | $0.0976 |
| 52-week low | $0.0916 |
| Median price | $0.1016 |
| Average price | $0.1009 |
| Largest weekly change | -23.1% (Apr 17, 2024) |
| Weeks tracked | 124 |
| Tracking since | May 24, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-6.1%
3Y
-18.6%
5Y
N/A
All
-12.3%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 48 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 48 MG TABLET, manufactured by Leading Pharma, LLC, is $0.0916 per EA (NDC 69315028709), effective Oct 1, 2025.
How has the price of FENOFIBRATE 48 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 48 MG TABLET has declined 12.3%. It has been tracked across 124 weekly CMS publications since May 24, 2023.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 48 MG TABLET?
Since May 24, 2023, the NADAC for FENOFIBRATE 48 MG TABLET has ranged from a low of $0.0847 (Apr 17, 2024) to a high of $0.1231 (Feb 14, 2024), with a median of $0.1016 per EA.
Are there cheaper alternatives to FENOFIBRATE 48 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENOFIBRATE 48 MG TABLET, is $0.0814 per EA — about 11% below FENOFIBRATE 48 MG TABLET.
Who manufactures FENOFIBRATE 48 MG TABLET?
FENOFIBRATE 48 MG TABLET (NDC 69315028709) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.